Clinical Trials Sponsored by Institut de Cancérologie de Lorraine

Total 5708 results

Instituto Nacional de Cancerologia, Columbia

Withdrawn

Curcumin in Advanced Cervical Cancer

Cervical Cancer, Stage IIB
Instituto Nacional de Cancerologia, Columbia

Active, not recruiting

Human Papilloma Virus (HPV) Self-collection and Women Adherence

Cervical Cancer | HPV Infection

Colombia
Instituto Nacional de Cancerologia, Columbia

Completed

Safety and Efficacy of Sorafenib in Patients With Advanced Thyroid Cancer: a Phase II Clinical Study

Thyroid Cancer

Colombia
Intergroupe Francophone de Cancerologie Thoracique
Groupe Français de Pneumo-Cancérologie

Completed

Strategies for Maintenance Therapies in Advanced Non Small Cell Lung Cancer

Advanced Non Small Cell Lung Cancer

France
Institut Cancerologie de l'Ouest
Fondation ARC

Active, not recruiting

64Cu-ATSM PET/CT in Rectum Cancer (TEP 64Cu-ATSM-Rectum)

Rectal Cancer

France
Institut Cancerologie de l'Ouest
Grünenthal GmbH

Completed

Evaluation in the Treatment of Neuropathic Pain Post Breast Surgery (CAPTRANE)

Breast Cancer Patient

France
Instituto Nacional de Cancerologia, Columbia

Terminated

Early Closure Versus Conventional Closure in Postoperative Patients With Low Anteriresection for Rectal Cancer

Colorectal Surgery | Colonic Neoplasms | Ileostomy - Stoma

Colombia
Instituto Nacional de Cancerologia, Columbia

Completed

Efficacy of 177-Lu-DOTA 0, Tyr 3 Octreotate

Neuroendocrine Tumors

Colombia
Instituto Nacional de Cancerologia, Columbia

Completed

ROLL vs WGLL for Non-palpable Breast Lesions (ROLLvsWGLL)

Breast Cancer
Institut Cancerologie de l'Ouest
Diagnostica Stago

Recruiting

Thrombin Generation and Prediction of Thromboembolic Events in Oncology Patients at Risk (THROMBIN)

Solid Carcinoma

France
Institut Cancerologie de l'Ouest
Grünenthal GmbH

Not yet recruiting

Capsaicin 179 mg Patch Versus Oral Duloxetine in Patients With Chemotherapy-induced Peripheral Neuropathy (CAPNEUCHIM)

Chemotherapy-induced Peripheral Neuropathy
Institut Cancerologie de l'Ouest
PHRC-I

Recruiting

Management of the Lack of Blood Return on a Central Venous Catheter (CVC) Before Chemotherapy (CATAREV-B)

Catheter Dysfunction

France
Institut Cancerologie de l'Ouest
SIRIC ILIAD

Completed

[18F]-DPA-714 PET/CT (Positron Emission Tomography/Computerized Tomography) in Triple Negative Breast Cancers (EITHICS)

Triple Negative Breast Cancer

France
Institut de cancérologie Strasbourg Europe
LEAF4Life, Inc.

Completed

A Study of Liposomal Trans Crocetin, LEAF-4L6715, in Patients With Acute Respiratory Distress Syndrome Due to COVID-19, Sepsis or Other Causes

Acute Respiratory Distress Syndrome | COVID19, Sepsis or Other Causes

France
Institut Cancerologie de l'Ouest

Completed

Cetuximab and Combination Chemotherapy in Treating Patients With Advanced or Metastatic Colorectal Cancer

Colorectal Cancer

France
Institut Cancerologie de l'Ouest

Unknown

Biomarkers in Predicting Neurotoxicity in Patients With Colorectal Cancer Receiving Oxaliplatin

Colorectal Cancer | Neurotoxicity | Chemotherapeutic Agent Toxicity

France
Centre Hospitalier Universitaire de Saint Etienne
Institut de Cancérologie de la Loire

Recruiting

Interest of PHARMaceutical Conciliation to Understand Drug Interactions, Phytotherapy, and Targeted Therapies in Chronic Myeloid Leukemia (PHARM-LMC)

Chronic Myeloid Leukemia

France
Centre Hospitalier Universitaire de Saint Etienne
Institut de Cancérologie de la Loire

Terminated

Constitution of a Biological Cohort Following Bone Marrow Sampling From MDS or AML Patients and Age-matched Healthy Donors (COSMOS)

Acute Myeloid Leukemia | Myelodysplastic Syndromes | Cardio-vascular Surgery

France
Centre Hospitalier Universitaire de Saint Etienne
Institut de Cancérologie de la Loire

Completed

Evolution of Thromboelastography During Tranexamic Acid Treatment (TTRAP-Bleeding)

Hematological Malignancies Treated With Intensive Chemotherapy

France
Centre Hospitalier Universitaire de Saint Etienne
Institut de Cancérologie de la Loire

Completed

A Randomized Study Evaluating the Incidence of Post Lumbar Puncture Headache With Atraumatic Needles in Hematology (SPPLAASH)

Lymphoma | Leukemia

France
Institut de Cancérologie de la Loire
Centre Hospitalier Lyon Sud

Completed

Safe Infusion Device in Reducing Occupational Exposure of Nurses (CONTAMOINS-1)

Cancer

France
Institut Cancerologie de l'Ouest
National Cancer Institute, France

Active, not recruiting

Evaluation of Different Smoking Cessation Protocols: Nicotine Replacement, Motivational Interviewing (MI), Cognitive Behavioural Therapy (CBT) or Hypnotherapy in Cancer Patients Scheduled for Surgery (RESPIRE)

Melanoma | Breast Cancer | Gynecologic Cancer | Digestive Cancer

France
Institut de cancérologie Strasbourg Europe
ICube Laboratory

Completed

Creation of a Probabilistic Atlas of Normal Cerebral Uptake of 18F-FDG in PET/MRI. (ATLATEP)

Brain Diseases

France
Hospital Civil de Guadalajara
Instituto Jalisciense de Cancerologia

Recruiting

The INVADE Study: INnominate Vein Approach for Central Catheterization in Difficult to cannulatE Patients (INVADE)

Critical Illness

Mexico
Centre Hospitalier Universitaire de Saint Etienne
Institut de Cancérologie de la Loire

Recruiting

Micro-transplantation in Elderly Patients With Acute Myeloid Leukemia (MTSA)

Acute Myeloid Leukemia

France
Centre Hospitalier Universitaire de Saint Etienne
Institut de Cancérologie de la Loire

Completed

Phase III Trial Evaluating Radium Bromatum Homeopathic Treatment Efficacy on Radiodermatitis Prevention and Treatment for Breast Cancer Women (HOMEORAD)

Breast Cancer

France
Centre Hospitalier Universitaire de Saint Etienne
Institut de Cancérologie de la Loire

Terminated

Post-SOPHrology Cancer Patients' anxieTY Report (SOPHTY)

Cancer

France
Centre Hospitalier Universitaire de Saint Etienne
Institut de Cancérologie de la Loire

Completed

Clinical Trial Assessing the Efficacy of Capsaicin Patch (Qutenza®) in Cancer Patients With Neuropathic Pain (CAPSONCO)

Neuropathic Pain

France
Instituto Nacional de Cancerologia de Mexico
Instituto Nacional de Enfermedades Respiratorias

Recruiting

Prophylactic Inhaled Steroids to Reduce Radiation Pneumonitis Frequency and Severity in Lung Cancer Patients

Radiation Pneumonitis

Mexico
Institut de cancérologie Strasbourg Europe
UR 3072

Recruiting

Characterization and Kinetic of Chemotherapy-induced Cardiovascular Toxicity in Breast Cancer (PROTECT-COEUR)

Breast Cancer

France
Centre Hospitalier Universitaire de Saint Etienne
Institut de Cancérologie de la Loire

Recruiting

Administration of Fibrinogen Concentrate for Refractory Bleeding (FORMAT)

Bleeding | Platelet Refractoriness | Hematological Patients

France
Centre Hospitalier Universitaire de Saint Etienne
Institut de Cancérologie de la Loire

Terminated

Trial Evaluating the Efficacy of the Combination of ROpivacaine With Reference XYlocaine in the Evaluation of Pain During the Installation of Percutaneous Radiological GASTrostomy (GASTROXY)

Cancer | Feeding Disorders

France
Centre Hospitalier Universitaire de Saint Etienne
Institut de Cancérologie de la Loire

Completed

High Dose Therapy Followed by Autologous Transplantation for Myeloma Patients With Severe Renal Impairment (IRMYG)

Multiple Myeloma | Renal Failure

France, Belgium, Algeria, Lebanon
Institut de Cancérologie de la Loire
Centre Hospitalier Universitaire de Saint Etienne

Unknown

Plan for Systematic Identification of Lung Cancers of Occupational Origin: Implementation Study (RECAP 2)

Broncho Pulmonary Cancer

France
Institut de Cancérologie de la Loire
Laboratoire ACTé; Education Nationale

Unknown

Interventional Research in Schools - Second Part (RISCOLAIRE2)

Healthy
Intergroupe Francophone de Cancerologie Thoracique
PharmaMar; Groupe Français de Pneumo-Cancérologie

Completed

RW Effectiveness of Lurbinectedin in Extensive Stage SCLC (LURBICLIN)

Small-cell Lung Cancer

France
Institut de Cancérologie de la Loire
Centre Leon Berard; Hospices Civils de Lyon

Unknown

Assesment of the Implementation of a Therapeutic Educational Intervention Affecting Adherence to Oral Chemotherapy (CHIMIO ORALE)

Neoplasm

France
Institut Cancerologie de l'Ouest
Astellas Pharma Inc

Active, not recruiting

Salvage Radiotherapy Combined With Hormonotherapy in Oligometastatic Pelvic Node Relapses of Prostate Cancer (OLIGOPELVIS)

Prostate Cancer

France
University Hospital, Tours
Institut Cancerologie de l'Ouest

Terminated

A Randomised Study of Docosahexaenoic Acid (DHA) in Metastatic Breast Cancer (DHALYA)

Metastatic Breast Cancer | Estrogen Receptor Positive Tumor | Progesterone Receptor Positive Tumor | HER-2 Negative Tumor

France
Instituto Nacional de Cancerologia de Mexico
Roche Pharma AG

Completed

Alectinib in Combination With Bevacizumab in ALK Positive NSCLC

ALK Gene Rearrangement Positive | Non-Squamous Non-Small Cell Neoplasm of Lung

Mexico
University Hospital, Montpellier
Institut de Recherche en Cancérologie de Montpellier (IRCM)

Unknown

Chemoresistance and Involvement of the NOTCH Pathway in Patients With Lung Adenocarcinoma (NOTCH)

Lung Adenocarcinoma

France
Groupe Français de Pneumo-Cancérologie

Recruiting

Mechanisms of Resistance to Amivantamab in Patients With NSCLC With EGFR Exon 20 Insertion (RESAMEX)

Non-small Cell Lung Cancer | EGFR Exon 20 Insertion Mutation

France
Federation Francophone de Cancerologie Digestive

Not yet recruiting

Study Evaluating the Benefit of Adding Ipilimumab to the Combination of Atezolizumab and Bevacizumab in Patients With Hepatocellular Carcinoma Receiving First-line Systemic Therapy (TRIPLET)

Metastatic Cancer | Metastatic Tumor | HCC - Hepatocellular Carcinoma

France
Intergroupe Francophone de Cancerologie Thoracique

Recruiting

ENCOrafenib With Binimetinib in bRAF NSCLC (ENCO-BRAF)

Non Small Cell Lung Cancer | BRAF V600E

France
Federation Francophone de Cancerologie Digestive

Recruiting

Systemic Oxaliplatin or Intra-arterial Chemotherapy Combined With LV5FU2 +/- Irinotecan and an Target Therapy in First Line Treatment of Metastatic Colorectal Cancer Restricted to the Liver (OSCAR)

Colorectal Neoplasms

France, Switzerland
Intergroupe Francophone de Cancerologie Thoracique

Active, not recruiting

Double Immune Checkpoint Inhibitors in PD-L1-positive Stage IV Non-small Lung CancEr (DICIPLE)

Non-Small Cell Lung Cancer Metastatic

France
Federation Francophone de Cancerologie Digestive

Completed

Efficacy and the Safety of Regorafenib in Patients Aged More Than 70 Years With a Metastatic Colorectal Adenocarcinoma . (REGOLD)

Colorectal Adenocarcinoma

France
Intergroupe Francophone de Cancerologie Thoracique

Active, not recruiting

Study of Osimertinib in Patients With a Lung Cancer With Brain or Leptomeningeal Metastases With EGFR Mutation (ORBITAL)

Non Small Cell Lung Cancer Metastatic | Brain Metastases | EGFR Activating Mutation | Leptomeningeal Metastasis

France
Intergroupe Francophone de Cancerologie Thoracique

Active, not recruiting

Atezolizumab in Elderly Patients With Advanced Non-Small-Cell Lung Cancer and Receiving Carboplatin Paclitaxel Chemotherapy (ELDERLY)

Non Small Cell Lung Cancer Metastatic

France
Groupe Français de Pneumo-Cancérologie

Completed

Epidemiologic Multicenter Prospective Study in Advanced NSCLC (Non Small Cell Lung Cancer) Patients With PDL1 (Protein Death Ligand 1) Expression. (EXPLORE-PDL1)

Lung Cancer

France

Clinical Trials Sponsored by Institut de Cancérologie de Lorraine

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malawi

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations